HomeINTS • NASDAQ
add
Intensity Therapeutics Inc
Previous close
$0.45
Day range
$0.42 - $0.58
Year range
$0.29 - $5.10
Market cap
8.53M USD
Avg Volume
1.04M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.39M | -28.44% |
Net income | -3.35M | 27.29% |
Net profit margin | — | — |
Earnings per share | -0.22 | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 929.00K | -91.15% |
Total assets | 3.06M | -75.30% |
Total liabilities | 2.73M | 1.68% |
Total equity | 334.00K | — |
Shares outstanding | 18.40M | — |
Price to book | 22.42 | — |
Return on assets | -216.23% | — |
Return on capital | -481.97% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -3.35M | 27.29% |
Cash from operations | -1.99M | 54.44% |
Cash from investing | — | — |
Cash from financing | 328.00K | 4,000.00% |
Net change in cash | -1.66M | -51.28% |
Free cash flow | -762.25K | 76.47% |
About
Founded
2012
Headquarters
Website
Employees
5
